Effectiveness of e-cigarettes as aids for smoking cessation: evidence from the PATH Study cohort, 2017–2019

• Published in: Tobacco control Vol. 32; no. e2; pp. e145 - e152
• Main Authors: Chen, Ruifeng, Pierce, John P, Leas, Eric C, Benmarhnia, Tarik, Strong, David R, White, Martha M, Stone, Matthew, Trinidad, Dennis R, McMenamin, Sara B, Messer, Karen
• Format: Journal Article
• Language: English
• Published: England BMJ Publishing Group Ltd 01.08.2023; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Abstinence; addiction; Adults; cessation; Cigarette industry; Cigarette smoking; Cigarettes; Cohort Studies; Drug addiction; Effectiveness; Electronic cigarettes; electronic nicotine delivery devices; Electronic Nicotine Delivery Systems; Households; Humans; Hypotheses; Longitudinal studies; Nicotine; Original Research; Response rates; Sales; Smoking; Smoking cessation; Smoking Cessation - methods; Statistical analysis; Surveillance and monitoring; Tobacco; Tobacco Use Cessation Devices; United States > US; electronic nicotine delivery devices; Surveillance and monitoring; addiction; cessation
• ISSN: 0964-4563; 1468-3318
• DOI: 10.1136/tobaccocontrol-2021-056901

ObjectiveTo assess the effectiveness of e-cigarettes in smoking cessation in the USA from 2017 to 2019, given the 2017 increase in high nicotine e-cigarette sales.MethodsIn 2017, the PATH Cohort Study included data on 3578 previous year smokers with a recent quit attempt and 1323 recent former smokers. Respondents reported e-cigarettes or other products used to quit cigarettes and many covariates associated with e-cigarette use. Study outcomes were 12+ months of cigarette abstinence and tobacco abstinence in 2019. We report weighted unadjusted estimates and use propensity score matched analyses with 1500 bootstrap samples to estimate adjusted risk differences (aRD).ResultsIn 2017, 12.6% (95% CI 11.3% to 13.9%) of recent quit attempters used e-cigarettes to help with their quit attempt, a decline from previous years. Cigarette abstinence for e-cigarette users (9.9%, 95% CI 6.6% to 13.2%) was lower than for no product use (18.6%, 95% CI 16.0% to 21.2%), and the aRD for e-cigarettes versus pharmaceutical aids was −7.3% (95% CI −14.4 to –0.4) and for e-cigarettes versus any other method was −7.7% (95% CI −12.2 to –3.2). Only 2.2% (95% CI 0.0% to 4.4%) of recent former smokers switched to a high nicotine e-cigarette. Subjects who switched to e-cigarettes appeared to have a higher relapse rate than those who did not switch to e-cigarettes or other tobacco, although the difference was not statistically significant.ConclusionsSales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse.